HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Implantable Defibrillators (Implantable Cardioverter-Defibrillator)

Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.
Also Known As:
Implantable Cardioverter-Defibrillator; Defibrillators, Implantable; Cardioverter Defibrillator, Implantable; Cardioverter Defibrillators, Implantable; Cardioverter-Defibrillator, Implantable; Defibrillator, Implantable; Defibrillator, Implantable Cardioverter; Defibrillators, Implantable Cardioverter; Implantable Cardioverter Defibrillators; Implantable Defibrillator; Cardioverter-Defibrillators, Implantable; Implantable Cardioverter Defibrillator; Implantable Cardioverter-Defibrillators
Networked: 7508 relevant articles (439 outcomes, 1048 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1. Zareba, Wojciech: 93 articles (01/2022 - 04/2003)
2. Moss, Arthur J: 87 articles (02/2019 - 04/2003)
3. McNitt, Scott: 82 articles (01/2022 - 10/2004)
4. Al-Khatib, Sana M: 69 articles (01/2022 - 05/2004)
5. Goldenberg, Ilan: 66 articles (01/2022 - 05/2006)
6. Kutyifa, Valentina: 58 articles (01/2022 - 03/2013)
7. Maron, Barry J: 51 articles (01/2022 - 03/2002)
8. Borggrefe, Martin: 50 articles (01/2022 - 12/2003)
9. Calkins, Hugh: 47 articles (01/2022 - 02/2003)
10. Dorian, Paul: 46 articles (11/2021 - 05/2003)

Related Diseases

1. Cardiac Sudden Death (Sudden Cardiac Arrest)
2. Ventricular Tachycardia
3. Heart Failure
11/15/2014 - "In conclusion, cardiac resynchronization therapy in combination with an implantable cardioverter-defibrillator resulted in improved survival among Medicare patients meeting class I criteria and most patients meeting class IIa criteria as outlined in the current guidelines for device-based therapy in heart failure, although the effect sizes were lower than those demonstrated in recent trials."
12/11/2018 - "Landmark studies have demonstrated the safety and efficacy of implantable cardioverter-defibrillators (ICDs) in selected stable ambulatory patients with heart failure (HF) with a reduced ejection fraction receiving optimal medical therapy. "
11/01/2013 - "The Resynchronization-Defibrillation for Ambulatory Heart Failure Trial showed that implantable cardioverter defibrillator-CRT was associated with a significant reduction in the primary end point of all-cause mortality or heart failure hospitalization. "
10/01/2012 - "In patients with an implantable defibrillator, remote monitoring is effective in identifying device malfunctioning and clinical problems, such as heart failure, to an extent similar to traditional ambulatory monitoring, while allowing significant advantages for the patient quality of life and savings in resource management. "
02/01/2012 - "IMPROVE HF, a 24-month performance improvement initiative for outpatient cardiology and multispecialty practices, demonstrated significant improvement in guideline-based use of implantable cardioverter-defibrillators (ICDs) for patients with heart failure (HF). "
4. Sudden Death
5. Cardiac Arrhythmias (Arrythmia)

Related Drugs and Biologics

1. Anti-Arrhythmia Agents
2. Adenosine Triphosphate (ATP)
3. Amiodarone (Amiodarona)
4. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
5. Angiotensin Receptor Antagonists
6. Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
7. Sotalol (Sotalol Hydrochloride)
8. Mineralocorticoid Receptor Antagonists
9. Quinidine (Chinidin)
10. Anticoagulants

Related Therapies and Procedures

1. Therapeutics
2. Cardiac Resynchronization Therapy
3. Secondary Prevention
4. Defibrillators (Defibrillator)
5. Catheter Ablation